Hyperfibrinolysis and Hypofibrinogenemia Diagnosed With Rotational Thromboelastometry in Dogs Naturally Infected With...

The underlying causes of bleeding disorders in canine patients suffering from parasitic infections remain poorly defined. No prior work had resolved the specific coagulation profiles associated with this condition. Clinicians often struggle to identify the exact mechanisms driving hemorrhage in these animals. That uncertainty drove the need for advanced diagnostic assessment tools. Prior research has shown that standard coagulation tests may fail to detect complex fibrinolysis issues. This gap motivated a detailed look at viscoelastic testing methods. Such evaluations offer a more comprehensive view of clot formation and degradation. Researchers aimed to bridge this knowledge deficit by analyzing patient data from a clinical setting.

The aim of this research was to characterize coagulation parameters in dogs naturally infected with the parasite Angiostrongylus vasorum. Investigators sought to clarify the pathomechanism behind the associated bleeding diathesis. No prior work had fully explained why these animals experience such severe clotting issues. That uncertainty drove the team to examine the utility of advanced viscoelastic testing. They specifically compared coagulation profiles between infected dogs with clinical signs of bleeding and those without. This study also evaluated the impact of therapeutic interventions on these laboratory findings. The researchers intended to provide clinical guidance for managing this complex condition. By analyzing patient records, they hoped to identify potential targets for effective medical treatment.

The review approach involved a retrospective analysis of clinical data from twenty-one canine patients. Investigators collected information from records spanning a three-year period starting in 2013. They retrieved details on platelet counts, coagulation parameters, and clinical bleeding manifestations. The team compared these variables between dogs showing signs of hemorrhage and those without such symptoms. Researchers utilized viscoelastic testing to characterize the clotting profiles of all subjects. They specifically examined the efficacy of tranexamic acid and plasma administration on patient outcomes. Statistical comparisons helped determine the significance of differences between the two study groups. This design allowed for a comprehensive assessment of the identified coagulation abnormalities.

Key findings from the literature reveal that hyperfibrinolysis occurred in 67% of symptomatic dogs, compared to 11% of asymptomatic ones. Severe hypofibrinogenemia was present in 60% of cases showing excessive clot breakdown. Tranexamic acid at doses of 10-80 mg/kg successfully resolved or reduced the hyperfibrinolysis. Plasma transfusions, ranging from 14-60 mL/kg, normalized fibrinogen function in 75% of the subjects. The overall survival rate to discharge reached 67% for the entire cohort. Statistical analysis showed no significant difference in survival between symptomatic and asymptomatic animals. These results confirm the prevalence of specific clotting defects in this parasitic disease. The data demonstrate that targeted medical management can effectively correct these laboratory abnormalities.

The authors propose that excessive clot breakdown and low fibrinogen levels represent a significant mechanism for hemorrhage in these canine patients. Synthesis and implications suggest that clinicians should consider these specific coagulation abnormalities when managing infected animals. The data indicate that tranexamic acid effectively addresses the observed hyperfibrinolysis. Plasma transfusions appear to successfully restore fibrinogen function as measured by specialized testing. The researchers note that these interventions normalize the identified clotting defects. Survival outcomes did not differ significantly between animals exhibiting bleeding signs and those that remained asymptomatic. These findings highlight the utility of viscoelastic monitoring in guiding therapeutic choices for this infection. The study provides a framework for addressing coagulopathy in naturally infected dogs.